95 related articles for article (PubMed ID: 16828171)
1. Recovery of human papillomavirus nucleic acids from liquid-based cytology media.
Powell N; Smith K; Fiander A
J Virol Methods; 2006 Oct; 137(1):58-62. PubMed ID: 16828171
[TBL] [Abstract][Full Text] [Related]
2. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
3. Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium.
Cuschieri KS; Beattie G; Hassan S; Robertson K; Cubie H
J Virol Methods; 2005 Mar; 124(1-2):211-5. PubMed ID: 15664071
[TBL] [Abstract][Full Text] [Related]
4. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
5. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
[TBL] [Abstract][Full Text] [Related]
7. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
[TBL] [Abstract][Full Text] [Related]
10. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
11. Improved detection of viral RNA isolated from liquid-based cytology samples.
Tarkowski TA; Rajeevan MS; Lee DR; Unger ER
Mol Diagn; 2001 Jun; 6(2):125-30. PubMed ID: 11468697
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
Jamison J; Wilson RT; Carson J
Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
[TBL] [Abstract][Full Text] [Related]
13. Development of optimal liquid based cytology sample processing methods for HPV testing: minimising the 'inadequate' test result.
Peevor R; Jones J; Fiander AN; Hibbitts S
J Virol Methods; 2011 May; 173(2):374-7. PubMed ID: 21295606
[TBL] [Abstract][Full Text] [Related]
14. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
15. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
16. Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system.
Broccolo F; Cocuzza CE
J Virol Methods; 2008 Mar; 148(1-2):48-57. PubMed ID: 18053585
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting successful DNA recovery from archival cervical smear samples.
Canfell K; Gray W; Snijders P; Murray C; Tipper S; Drinkwater K; Beral V
Cytopathology; 2004 Oct; 15(5):276-82. PubMed ID: 15456416
[TBL] [Abstract][Full Text] [Related]
18. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
19. Detection and genotyping analysis of human papillomavirus isolates from liquid-based cervical cytology specimens.
Avissar P; Malinowski DP
Methods Mol Biol; 2009; 511():361-70. PubMed ID: 19347306
[TBL] [Abstract][Full Text] [Related]
20. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR.
Marks M; Gupta SB; Liaw KL; Kim E; Tadesse A; Coutlee F; Sriplienchan S; Celentano DD; Gravitt PE
J Virol Methods; 2009 Mar; 156(1-2):152-6. PubMed ID: 19022296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
